Aras Toker
BioNTech (Germany)(DE)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, CAR-T cell therapy research, T-cell and B-cell Immunology
Most-Cited Works
- → Active Demethylation of the Foxp3 Locus Leads to the Generation of Stable Regulatory T Cells within the Thymus(2013)259 cited
- → Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors(2022)108 cited
- → Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma(2018)102 cited
- → Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5(2022)74 cited
- → WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity(2021)61 cited
- → Turning the Tide Against Regulatory T Cells(2019)55 cited
- → Naïve blood monocytes suppress T‐cell function. A possible mechanism for protection from autoimmunity(2010)46 cited
- → Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer(2019)38 cited
- → DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity(2022)36 cited
- → Expression of costimulatory and inhibitory receptors in FoxP3+ regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches(2019)35 cited